Kidney Angiomyolipoma has emerging NIH research funding with 1 grant totaling $1.2M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Kidney Angiomyolipoma. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.
8 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for kidney angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
49 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for kidney angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
20 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for kidney angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
8 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for kidney angiomyolipoma. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Kidney Angiomyolipoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.